HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.

AbstractBACKGROUND:
Acute-serum Amyloid A (A-SAA), one of the major acute-phase proteins, is mainly produced in the liver but extra-hepatic synthesis involving the skin has been reported. Its expression is regulated by the transcription factors NF-κB, C/EBPβ, STAT3 activated by proinflammatory cytokines.
OBJECTIVES:
We investigated A-SAA synthesis by resting and cytokine-activated Normal Human Epidermal Keratinocytes (NHEK), and their inflammatory response to A-SAA stimulation. A-SAA expression was also studied in mouse skin and liver in a model mimicking psoriasis and in the skin and sera of psoriatic and atopic dermatitis (AD) patients.
METHODS:
NHEK were stimulated by A-SAA or the cytokines IL-1α, IL-17A, IL-22, OSM, TNF-α alone or in combination, previously reported to reproduce features of psoriasis. Murine skins were treated by imiquimod cream. Human skins and sera were obtained from patients with psoriasis and AD. A-SAA mRNA was quantified by RT qPCR. A-SAA proteins were dosed by ELISA or immunonephelemetry assay.
RESULTS:
IL-1α, TNF-α and mainly IL-17A induced A-SAA expression by NHEK. A-SAA induced its own production and the synthesis of hBD2 and CCL20, both ligands for CCR6, a chemokine receptor involved in the trafficking of Th17 lymphocytes. A-SAA expression was increased in skins and livers from imiquimod-treated mice and in patient skins with psoriasis, but not significantly in those with AD. Correlations between A-SAA and psoriasis severity and duration were observed.
CONCLUSION:
Keratinocytes could contribute to psoriasis pathogenesis via A-SAA production, maintaining a cutaneous inflammatory environment, activating innate immunity and Th17 lymphocyte recruitment.
AuthorsElodie Couderc, Franck Morel, Pierre Levillain, Amandine Buffière-Morgado, Magalie Camus, Camille Paquier, Charles Bodet, Jean-François Jégou, Mathilde Pohin, Laure Favot, Martine Garcia, Vincent Huguier, Jiad Mcheik, Corinne Lacombe, Hans Yssel, Gérard Guillet, François-Xavier Bernard, Jean-Claude Lecron
JournalPloS one (PLoS One) Vol. 12 Issue 7 Pg. e0181486 ( 2017) ISSN: 1932-6203 [Electronic] United States
PMID28708859 (Publication Type: Journal Article)
Chemical References
  • Aminoquinolines
  • Chemokine CCL20
  • Cytokines
  • Interleukin-17
  • Receptors, CCR6
  • Recombinant Proteins
  • Serum Amyloid A Protein
  • Imiquimod
Topics
  • Adult
  • Aged
  • Aminoquinolines (pharmacology)
  • Animals
  • Cells, Cultured
  • Chemokine CCL20 (metabolism, pharmacology)
  • Cytokines (genetics, metabolism)
  • Dermatitis, Atopic (metabolism, pathology)
  • Disease Models, Animal
  • Female
  • Humans
  • Imiquimod
  • Interleukin-17 (genetics, metabolism, pharmacology)
  • Keratinocytes (cytology, drug effects, metabolism)
  • Liver (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged
  • Psoriasis (metabolism, pathology)
  • Receptors, CCR6 (metabolism)
  • Recombinant Proteins (biosynthesis, isolation & purification, pharmacology)
  • Serum Amyloid A Protein (analysis, genetics, metabolism)
  • Skin (drug effects, metabolism)
  • Th17 Cells (cytology, metabolism)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: